Jie Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jie Zhou has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Hai-Tao Gu
Department of Pediatric Cardiothoracic Surgery, Jiangsu Women and Children Health Center, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 shared publicationsHong Liu
Department of Cardiac Surgery, Clinical Center of Heart and Great Vessels, Research Institute of Heart, Lung, and Blood Vessel Diseases, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 shared publicationsQiao-Ling Feng
Ministry of Education Key Laboratory of Clinical Diagnostic Medicine, Institute of Laboratory Medicine, Chongqing Medical University, Chongqing, China
2 shared publicationsFei Yan
Paul C. Lauterbur Research Center for Biomedical Imaging, Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
1 shared publicationGang Wan
Department of Radiation Oncology, Affiliated Cancer Hospital of Guangxi Medical University, Nanning, China
1 shared publicationJia-Yin Liu
State Key Laboratory of Reproductive Medicine, Clinical Center of Reproductive Medicine, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
1 shared publication
Latest Publications
- Open Access
- 1 June 2015
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 169 (6) , 603-605
Association Between Assisted Reproductive Technology and Cardiac Alteration at Age 5 Years
Assisted reproductive technology (ART) has extensively permitted thousands of childbirths per year for many infertile couples throughout the world. Although ART
- 1 June 2015
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 169 (6) , 603-605
Open AccessAssociation Between Assisted Reproductive Technology and Cardiac Alteration at Age 5 Years
Assisted reproductive technology (ART) has extensively permitted thousands of childbirths per year for many infertile couples throughout the world. Although ART
- Open Access
Minimally invasive endoscopic staging for mediastinal lymphadenopathy in lung cancer: a systematic review protocol
Introduction Minimally invasive endoscopic biopsy techniques have been widely available as potential alternatives for mediastinal lesions staging in patients with known or suspected lung cancer. Previous efforts have been made to evaluate the diagnostic performance of specific endoscopic modality alone at the level of the mediastinum for staging lung cancer, however, few studies focus on the accuracy of comparisons between different endoscopic modalities, especially at the level of any individual lymph node station. The objective of our study is to determine the diagnostic yields of different endoscopic modalities for staging mediastinal lymphadenopathy in lung cancer, especially concerning the individual lymph node station. Methods/design A systematic electronic search of MEDLINE, EMBASE, SinoMed and ISI Web of Science were performed to identify studies evaluating endoscopic modalities accuracy with restriction of English and Chinese languages from inception to an update until May 2014. Data were extracted with the patient as the unit of analysis with regards to the abilities of different endoscopic modalities at the level of mediastinum and particular lymph node station. The methodological quality was assessed independently according to the Quality Assessment of Diagnostic Accuracy Study (QADAS) criteria. An exact binomial rendition of bivariate mixed-effects regression model was used to estimate the pooled sensitivity and specificity. Also, pre–post probability analysis, publication bias analysis and sensitivity analysis were performed for a synthesis of knowledge of this context. Dissemination The findings will advance our better available knowledge of optimal clinical decision-making when dealing with staging of mediastinal metastasis in lung cancer. Trial registration number PROSPERO—NIHR Prospective Register of Systematic Reviews (CRD42014009792).
Open AccessMinimally invasive endoscopic staging for mediastinal lymphadenopathy in lung cancer: a systematic review protocol
Introduction Minimally invasive endoscopic biopsy techniques have been widely available as potential alternatives for mediastinal lesions staging in patients with known or suspected lung cancer. Previous efforts have been made to evaluate the diagnostic performance of specific endoscopic modality alone at the level of the mediastinum for staging lung cancer, however, few studies focus on the accuracy of comparisons between different endoscopic modalities, especially at the level of any individual lymph node station. The objective of our study is to determine the diagnostic yields of different endoscopic modalities for staging mediastinal lymphadenopathy in lung cancer, especially concerning the individual lymph node station. Methods/design A systematic electronic search of MEDLINE, EMBASE, SinoMed and ISI Web of Science were performed to identify studies evaluating endoscopic modalities accuracy with restriction of English and Chinese languages from inception to an update until May 2014. Data were extracted with the patient as the unit of analysis with regards to the abilities of different endoscopic modalities at the level of mediastinum and particular lymph node station. The methodological quality was assessed independently according to the Quality Assessment of Diagnostic Accuracy Study (QADAS) criteria. An exact binomial rendition of bivariate mixed-effects regression model was used to estimate the pooled sensitivity and specificity. Also, pre–post probability analysis, publication bias analysis and sensitivity analysis were performed for a synthesis of knowledge of this context. Dissemination The findings will advance our better available knowledge of optimal clinical decision-making when dealing with staging of mediastinal metastasis in lung cancer. Trial registration number PROSPERO—NIHR Prospective Register of Systematic Reviews (CRD42014009792).